(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane

Product Details

CAS No:98737-29-2

MF:C15H21NO3

Appearance:white or off-white crystalline powder

Specification:98.5%

UN number:UN 3077 9/PG III

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Product application:(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane, CAS 98737-29-2, Boc-L-Phenylalanine Epoxide, Darunavir intermediate, Atazanavir intermediate, tert-Butyl [(1S)-1-((2S)-oxiranyl)-2-phenylethyl]carbamate, Chiral pharmaceutical intermediates, HIV protease inhibitor building blocks, 98737-29-2 manufacturer.

Synonyms:(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane;tert-Butyl ((S)-(R,R))-(-)-(1-oxiranyl-2-phenylethyl)carbamate; 1-Benzyl-2,3-epoxypropyl-carbamic acid tert-butyl estertert-Butyl [(S)-1-[(S)-Oxiran-2-yl]-2-phenylethyl]carbamate (2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane;(2R,3S)-1,2-Epoxy-3-(Boc-aMino)-4-phenylbutane, 95+%;(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane 99%;(2S,3S)-3-Boc-amino-1,2-epoxy-4-phenylbutane, >=99%;3S-(T-BOC)AMINO-1,2-(S)-EPOXY-4-PHENYLBUTANE;[(1S)-1-((2S)-Oxiranyl)-2-phenylethyl]carbaMic Acid tert-Butyl;TERT-BUTYL [S-(R,R)]-(-)-(1-OXIRANYL-2-PHENYLETHYL)CARBAMATE;T-BUTYL [S-(R*,R*)]-(-)-(1-OXIRANYL-2-PHENYLETHYL)CARBAMATE;(2S,3S)-(-)-3-tert-Butoxycarbonylamino-1,2-epoxy-4-phenylbutane","(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane; tert-butyl N-[(1S)-1-[(2S)-oxiran-2-yl]-2-phenylethyl]carbamate; EC 425-420-5; DTXSID801173325; (2S,3S)-(-)-3-tert-Butoxycarbonylamino-1,2-epoxy-4-phenylbutane; tert-Butyl (1S)-N-(1-((2S)-2-oxiranyl)-2-phenylethyl)carbamate; tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate; tert-Butyl N-[(1S)-1-((2S)-Oxiran-2-yl)-2-phenylethyl]carbamate; tert-butyl N-((1S)-1-((2S)-oxiran-2-yl)-2-phenylethyl)carbamate; DTXCID601604718; 425-420-5; 619-373-1; 98737-29-2; (2S,3S)-N-t-Boc-3-amino-1,2-epoxy-4-phenylbutane; (2S,3S)-3-Boc-amino-1,2-epoxy-4-phenylbutane; MFCD02258997; (2S,3S)-(-)-3-(t-BOC-amino)-1,2-Epoxy-4-phenylbutane; 286019-82-7; tert-Butyl ((S)-1-((S)-oxiran-2-yl)-2-phenylethyl)carbamate; tert-Butyl rel-((S)-1-((S)-oxiran-2-yl)-2-phenylethyl)carbamate; Tert-butyl N-[(1S)-1-[(2S)-oxiran-2-yl]-2-phenyl-ethyl]carbamate; (2S,3S)-1,2-Epoxy-3-(tert-butoxycarbonylamino)-4-phenylbutane; Atazanavir Impurity 10; tert-Butyl [S-(R*,R*)]-(-)-(1-oxiranyl-2-phenylethyl)carbamate; tert-Butyl [(S)-1-[(S)-Oxiran-2-yl]-2-phenylethyl]carbamate; (2S,3S)-3-(Boc-amino)-1,2-epoxy-4-phenylbutane; (2S,3S)-N-Boc-3-amino-1,2-epoxy-4-phenylbutane; (2S,3S)-3-(tert-Butoxycarbonylamino)-1,2-epoxy-4-phenylbutane; SCHEMBL1104909; BCP12784; Tert-butyl {(1S)-1-[(2S)-oxiran-2-yl]-2-phenylethyl}carbamate; AC7771; AKOS015894820; CS-W002934; FB18916; GS-3357; SY014525; E0893; t-butyl [1(S)-benzyl-2(S),3-epoxypropyl]carbamate; (2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane, 99%; tert-butyl (1S)-1-[(2S)-oxiranyl]-2-phenylethylcarbamate; tert-butyl(S)-1-((S)-oxiran-2-yl)-2-phenylethylcarbamate; (2S, 3S)-3-tert-butoxycarbonylamino-1,2-epoxy-4-phenylbutane; (2S,3S)-3-tert-butoxycarbonylamino-1,2-epoxy-4-phenylbutane; 3(S)-(t-butyloxycarbonyl)amino-1,2(S)-epoxy-4-phenylbutane; tert-Butyl (1S)-1-[(2S)-oxiran-2-yl]-2-phenylethylcarbamate; tert-Butyl(1S)-1-[(2S)-oxiran-2-yl]-2-phenylethylcarbamate; ((S)-(S)-1-oxiranyl-2-phenyl-ethyl)-carbamic acid tert-butyl ester; ((S)-1-(S)-oxiranyl-2-phenyl-ethyl)-carbamic acid tert-butyl ester; Tert-Butyl ((S)-(R,R))-(-)-(1-oxiranyl-2-phenylethyl)carbamate; TERT-BUTYL (S)-1-((S)-OXIRAN-2-YL)-2-PHENYLETHYLCARBAMATE; 1,1-dimethylethyl {(1S)-1-[(2S)-2-oxiranyl]-2-phenylethyl}carbamate; N-[(1S)-1-[(2S)-2-Oxiranyl]-2-phenylethyl]-carbamic Acid 1,1-Dimethylethyl Ester; N-[(1S)-1-[(2S)-2-Oxiranyl]-2-phenylethyl]-carbamic acid 1,1-dimethylethyl ester;(2S,3S)-(-)-3-tert-Butoxycarbonylamino-1,2-epoxy-4- phenylbutane;[(1S)-1-((2S)-Oxiranyl)-2-phenylethyl]carbamic acid tert-butyl ester",263.330,C15H21NO3,;